50% off Premium Yearly

TSE:L
This summary was created by AI, based on 11 opinions in the last 12 months.
Loblaw Companies Ltd, a leading food and drug retailer in Canada, has experienced significant growth, especially following its acquisition of Shoppers Drug Mart. Experts note its strong performance amid food inflation, and the success of its No Frills discount brand has drawn positive attention. However, concerns about overvaluation are prevalent, with many analysts watching for signs of sustainable growth, especially with increasing competition from Walmart and Costco. While some view the company as a solid defensive investment, others are cautious, indicating that current valuations appear stretched compared to historical standards. Analysts provide mixed views on its future performance, recommending investors consider alternatives in the retail space.
Just reported a weak quarter. Earnings were down. Having distribution problems as they switch over to Great Canadian Super stores. Their margins are still the best by far. Feels there's another tough quarter coming, but they are good operators and will eventually get it fixed. Has been buiying on weakness.